A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients With MPS II Who Are Receiving Elaprase and Started Treatment With Elaprase at <6 Years of Age
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 May 2018
At a glance
- Drugs Idursulfase (Primary)
- Indications Mucopolysaccharidosis II
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shire
- 18 May 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Jan 2016 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 03 Jun 2015 New trial record